About Sonavex
Sonavex is a company based in Baltimore (United States) founded in 2013. Sonavex has raised $30.53 million across 19 funding rounds from investors including NIH, HHS and Partners Capital. The company has 11 employees as of December 31, 2024. Sonavex offers products and services including EchoMark and EchoSure. Sonavex operates in a competitive market with competitors including Augmedics, Proprio, ClearPoint Neuro, IMRIS Deerfield Imaging and eCential Robotics, among others.
- Headquarter Baltimore, United States
- Employees 11 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sonavex Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$30.53 M (USD)
in 19 rounds
-
Latest Funding Round
$15 M (USD), Series A
Oct 24, 2024
-
Investors
NIH
& 17 more
-
Employee Count
11
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sonavex
Sonavex offers a comprehensive portfolio of products and services, including EchoMark and EchoSure.
Ultrasound marker for blood vessels in dialysis monitoring
Device for detecting flow, diameter, and depth in vessels
People of Sonavex
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Sonavex
Sonavex has successfully raised a total of $30.53M across 19 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sonavex
Sonavex has secured backing from 18 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Partners Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in medical and construction technology.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early-stage investments are made in regulated industries by Riptide Ventures.
|
Locked | Locked | Locked |
Investor details for Sonavex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sonavex
Investment portfolio details for Sonavex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sonavex
Detailed financials for Sonavex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sonavex Comparisons
Peer comparison for Sonavex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sonavex
Sonavex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, Proprio, ClearPoint Neuro, IMRIS Deerfield Imaging and eCential Robotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| Locked | Locked | Locked |
Visualization systems for surgical procedures are developed using machine learning.
|
|
| Locked | Locked | Locked |
Software and hardware solutions for MRI-guided surgical planning are provided.
|
|
| Locked | Locked | Locked |
Surgical theatres with ceiling mounted mobile imaging devices to enhance intraoperative workflow
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Developer of surgical navigation and image guidance system for endovascular procedures
|
Detailed competitors of Sonavex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sonavex
Complete news archive for Sonavex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sonavex
Sonavex was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Sonavex is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Sonavex is a funded company, having raised a total of $30.53M across 19 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Sonavex is 11.
Sonavex was founded in 2013 and is headquartered in Baltimore, United States. Operations focus on the healthcare sector, where ultrasound-based imaging is developed for detecting anastomotic blood clots during surgical procedures. The solution consists of two components: EchoMark, an absorbable marker used to outline the surgical site, and EchoFind, a tool for positioning guidance and blood flow data extraction. This approach aids in preventing complications from surgical failures.
Sonavex's top competitors include Augmedics, Proprio and ClearPoint Neuro.
Sonavex offers EchoMark and EchoSure.
Sonavex has 18 investors. Key investors include NIH, HHS, Partners Capital, TEDCO, and Oakwood Circle Ventures.